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Uric acid (UA) crystals are a potent stimulator of inflammation, but how they activate immune cells is not
known. In this issue of Immunity, Ng et al. (2008) provide evidence suggesting that UA activates the Syk
kinase via membrane cholesterol.
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PreviewsAbout 20 years ago, Charles Janeway
proposed that adaptive immune re-
sponses are dependent upon recognition
of microbe components (‘‘pathogen-as-
sociated molecular patterns,’’ or PAMPs)
by receptors on immune cells (‘‘pattern-
recognition receptors’’) (Janeway, 1992).
Polly Matzinger alternatively proposed
that initiation of adaptive immune re-
sponses was dependent on ‘‘danger’’ sig-
nals (Matzinger, 1994). Both of these con-
cepts are now widely accepted as being
correct, and there has been remarkable
progress in defining the receptors and
the ligands recognized by those recep-
tors, both for ligands coming from infec-
tious agents and for ligands that are ex-
pressed upon cellular stress or released
from dying cells. Nonetheless, major
questions remain, one of which is ad-
dressed by Ng et al. (2008) in this issue
of Immunity. The article attempts to re-
solve how dendritic cells recognize uric
acid crystals, which can precipitate
when necrotic cells release cytoplasmic
metabolites and which are known to
have adjuvant properties and to be re-
sponsible for the severe innate inflamma-
tion in gout. The surprising suggestion of
these studies is that membrane lipids
and, more specifically, cholesterol may
be key components of the interaction be-
tween uric acid crystals and dendritic
cells; this interaction leads to the matura-
tion of the dendritic cells.
The view that proteins serve as cellular
receptors for hormones, antigens, and cy-
tokines, etc. is one of the pillars of modern
cellular and molecular biology, and many
approaches for identifying receptors
have been developed. Most of these ap-
proaches are not, however, well suited
for use with a crystal ligand. To study
how uric acid interacts with immune cells,
Ng et al. (2008) turned to the technique of
atomic-force microscopy. They attached670 Immunity 29, November 14, 2008 ª2008small crystals of uric acid to the cantilever
of the atomic-force microscope and mea-
sured the strength of association between
a uric acid crystal and various cells. Inter-
estingly, dendritic cells exhibited strong
adhesion to uric acid crystals, whereas
several other cell types (fibroblasts, etc.)
did not. The overall strength of this asso-
ciation was sufficiently strong to suggest
that it is biologically important. Moreover,
dendritic cells failed to bind two other
crystals, calcium phosphate crystals and
allopurinol crystals, indicating some level
of specificity. Atomic-force microscopy
therefore provided an assay for probing
the nature of the interaction between
uric acid and immune cells. Interestingly,
extraction of cholesterol from the den-
dritic cell plasma membrane with
methyl-b-cyclodextran abolished binding
of uric acid crystals and also prevented
dendritic cell maturation in response to
uric acid crystals, but it did not prevent
maturation in response to Toll-like recep-
tor ligands. Conversely, evidence for
a protein receptor was not obtained. In
particular, pronase treatment of the den-
dritic cells, which removed approximately
90% of cell surface proteins, did not
greatly affect the strength of adhesion of
uric acid crystals to dendritic cells. In sup-
port of the idea that cholesterol in the
plasmamembrane of dendritic cellsmedi-
ated the binding to uric acid crystals, im-
aging by fluorescencemicroscopy of cho-
lesterol in the membrane of dendritic cells
interacting with uric acid clearly showed
a concentration of cholesterol at the site
of contact between the dendritic cell and
the uric acid crystal. Several other phos-
pholipids in the dendritic cell membrane
failed to redistribute in this way. More-
over, the authors were able to use
atomic-force microscopy to detect direct
interaction between uric acid crystals
and artificial membrane bilayers contain-Elsevier Inc.ing cholesterol. Thus, the authors pre-
sented several pieces of evidence point-
ing to some relationship between uric
acid crystals and the lipid cholesterol in
themembrane of dendritic cells (Figure 1).
The authors suggest that this interaction
is responsible for the adjuvant and inflam-
mation-inducing properties of uric acid
crystals. Of course, these studies do not
exclude the possibility that there is a pro-
tein receptor involved in this recognition.
Although these observations are con-
sistent with the idea that uric acid crystals
associate with cholesterol in the mem-
brane of dendritic cells, they raise many
questions. First and foremost, what is
the biological consequence of this inter-
action between uric acid crystals and
dendritic cell membranes? The authors
observed that strong binding of dendritic
cells to uric acid was blocked by several
inhibitors of intracellular protein kinases,
including an inhibitor for Syk. Moreover,
dendritic cells from Syk-deficient mice
were also deficient in binding to uric
acid. Examination of phosphorylation of
Syk on an activating tyrosine residue by
intracellular staining with a phospho-
specific antibody and flow cytometry re-
vealed that addition of uric acid crystals
to dendritic cells induced a clear increase
in phospho-Syk staining. Thus, uric acid
crystal binding to cells induces activation
of the Syk tyrosine kinase, but conversely,
Syk is required for strong binding to oc-
cur. To explain these results, the authors
propose that uric acid binding to dendritic
cells induces Syk activation, which in turn
promotes stronger binding. An alternative
hypothesis would be that uric acid binds
to a protein receptor that activates
Syk and that this signaling promotes
stronger binding by a mechanism that
requires either cholesterol or the mem-
brane lipid rafts that require cholesterol
for their stability and might involve either
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Previewsprotein-based adhesion or cholesterol-
based adhesion. Syk-induced upregula-
tion of adhesion appears to require
reorganization of the actin-based cyto-
skeleton given that cytochalasin B, an
inhibitor of actin polymerization, also
blocked strong adhesion of uric acid crys-
tals to dendritic cells. This is consistent
with a role for Syk in actin polymerization
downstream of other receptors (Berton
et al., 2005).
Figure 1. Proposed Interaction of Uric Acid
Crystals with Dendritic Cell Membranes
Evidence presented by Ng et al. (2008) demon-
strates that specific interactions of uric acid crys-
tals occur with dendritic cells. These interactions
appear to involve membrane cholesterol and also
require the protein tyrosine kinase Syk and actin
polymers. The interaction of these crystals with
the dendritic cell membrane leads to activation of
Syk, which might mediate either internalization
of the crystal or a cellular response to the binding
of the crystal.These studies also raise the question
of why uric acid crystals associate with
dendritic cells but not with fibroblasts,
which also have cholesterol in their
plasma membrane. The authors did not
address this question with experiments,
but they did suggest that it might be be-
cause Syk expression and its signaling
mechanism are largely restricted to he-
matopoietic cells. This explanation
would predict that other cell types that
express Syk and utilize it for their func-
tion, such as B lymphocytes, would
bind avidly to uric acid crystals and
would respond to them by activating
Syk and BCR-like signaling. Finally, do
the direct binding of uric acid crystals
to dendritic cell membranes and the ac-
tivation of Syk signaling contribute to the
activation of the inflammasome by uric
acid (Martinon et al., 2006), which is
likely to be a critical mechanism for the
pathogenesis of gout? Recent evidence
has suggested that several kinds of in-
flammasome-activating crystals, includ-
ing uric acid crystals, are internalized
into phagosomes and cause rupture of
the phagosomes, after which the NALP-
3 inflammasome is activated by the
released phagosomal contents (Hornung
et al., 2008). These recent studies ad-
dress what happens after crystals are
internalized by phagocytes, but they do
not indicate how that internalization
might happen and thus may be comple-
mentary to the studies in the article by
Ng et al. (2008).
Both the Ng et al. (2008) studies of bind-
ing of uric acid crystals to dendritic cells
and those of Hornung et al. (2008), whoImmunity 29,imaged the fate of crystals within phago-
somes, suggest that some or all of the im-
munological effects of inflammation-
inducing crystals are mediated by their
effects on membranes rather than via
specific recognition proteins. Thus, we
may have a new paradigm to add to our
thinking about the regulation of inflamma-
tion. Nonetheless, there are several
important questions that need to be ad-
dressed before many in the immunologi-
cal community will view as attractive the
idea that uric acid crystals bind directly
to membrane lipids to initiate cellular re-
sponses. Ng et al. (2008) have given us
some concrete tools (atomic-force mi-
croscopy) and signaling mechanisms
(Syk and ITAM signaling) with which to ad-
dress this hypothesis, and we can expect
to see a flurry of studies addressing the in-
teresting issue of how innate immune cells
respond to uric acid crystals.
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